Format

Send to

Choose Destination
Biochem Biophys Res Commun. 2008 Aug 29;373(3):440-4. doi: 10.1016/j.bbrc.2008.06.058. Epub 2008 Jun 25.

TGF-beta activates ERK5 in human renal epithelial cells.

Author information

1
South West Thames Institute for Renal Research, St. Helier Hospital, Carshalton, Surrey SM5 1AA, UK. james.browne@epsom-sthelier.nhs.uk

Abstract

The role of the MAP kinase, extracellular signal-regulated kinase 5 (ERK5) remains unknown, however it is involved in cell differentiation and survival as highlighted by the embryonic lethality of the ERK5 knockout. ERK5 can be activated by growth factors and other extracellular signals. TGF-beta, a powerful controller of epithelial cell phenotype, is known to activate the MAP kinase, ERK1/2 however its effect on ERK5 remains unknown. This study demonstrates, fort the first time, ERK5 activation by TGF-beta, observed in both transformed and primary adult human PTEC; activation required ALK-5 receptor activity. In addition this work demonstrates expression of myocyte enhancer factor-2 (MEF2C) by PTEC and that TGF-beta increased the association of MEK5 with phospho-ERK5 and MEF2C. ERK5 activation by either TGF-beta or epidermal growth factor (EGF) was also inhibited by the p38 MAP kinase inhibitor, SB-202190.

PMID:
18588859
DOI:
10.1016/j.bbrc.2008.06.058
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center